nifedipine has been researched along with Albuminuria in 47 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present analysis, we used data from the TALENT study to evaluate soluble receptor for advanced glycation end-products (sRAGE) plasma levels in patients with hypertension and high-cardiovascular risk-treated nifedipine and telmisartan in combination." | 9.16 | Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT. ( Boiocchi, C; Bozzini, S; Buzzi, MP; Choi, J; D'Angelo, A; Esposito, C; Falcone, C; Mancia, G; Ochan Kilama, M; Schirinzi, S; Torreggiani, M, 2012) |
| "Long-term control of blood pressure with perindopril or nifedipine stabilizes AER and attenuates GFR decline in proportion to MAP in non-hypertensive patients with Type 2 diabetes and microalbuminuria." | 9.11 | Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. ( Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; O'Brien, RC; Raffaele, J; Tsalamandris, C, 2004) |
| "These findings suggest that the low-dose combination therapy of nifedipine CR and candesartan is superior to the up-titrated monotherapy of candesartan in terms of blood pressure control and renal protection in patients with essential hypertension." | 9.11 | Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study. ( Hasebe, N; Kikuchi, K, 2005) |
| "The purpose of the study was to compare the effect of treatment with an angiotensin converting enzyme inhibitor (Lisinopril, MSD) or calcium blocker (Nifedipine retard, MSD) treatment during three months on blood pressure (measured with sphygmomanometric method and ambulatory blood pressure monitoring--ABPM) and urinary albumin excretion in essential hypertension class I acc." | 9.08 | [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension]. ( Celibała, R; Czekalski, S; Widecka, K, 1995) |
| "Our data show that both lisinopril and nifedipine are effective in delaying the occurrence of macroalbuminuria in normotensive IDDM patients with MA." | 9.08 | Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. ( Carta, Q; Crepaldi, G; Deferrari, G; Mangili, R; Navalesi, R; Nosadini, R; Santeusanio, F; Spalluto, A; Vanasia, A; Villa, GM, 1998) |
| "To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 9.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
| "The aim of the present study was to investigate the renal effects of long-term treatment with the calcium channel blocker nifedipine in normotensive type 1 diabetic patients with microalbuminuria." | 9.07 | Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. ( Banyai, M; Capek, M; Kautzky-Willer, A; Prager, R; Schernthaner, G; Schnack, C, 1994) |
| "Randomised study of diabetic patients with microalbuminuria treated with perindopril or nifedipine for 12 months and monitored for one or three months after stopping treatment depending on whether they were hypertensive or normotensive." | 9.07 | Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. ( , 1991) |
| " Reduction of microalbuminuria at 27 weeks, compared to the vehicle group, was 37% and 52% in the enalapril- and nilvadipine-treated groups, respectively." | 7.72 | Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes. ( Imai, E; Moriyama, T; Oka, K; Ueda, H, 2004) |
| " In the first 3 months, drug dosage was titrated to achieve a decrease in diastolic blood pressure of at least 5 mm HG: Thirty-three patients had a minimum of 24 months' data, and 25 patients were followed up beyond 36 months (mean, 67 +/- 4 months)." | 6.70 | Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. ( Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; Raffaele, J; Tsalamandris, C, 2001) |
| "Treatment with enalapril for 48 months may have a beneficial effect on the decline of microalbumin excretion in NIDDM patients." | 6.67 | Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. ( Hara, T; Hotta, N; Kawamura, T; Matsumae, H; Matsuo, S; Nakayama, M; Sakamoto, N; Sano, T; Sasaki, H, 1994) |
| "Twelve patients with type 1 diabetes with albuminuria, mild to moderate hypertension and a serum creatinine level of less than 200 mumol l-1 were included." | 6.67 | Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. ( Berg, KJ; Djøseland, O; Endresen, L; Fauchald, P; Hartmann, A; Holdaas, H; Jervell, J; Lien, MG; Nilsen, L, 1991) |
| "Twenty-five stage 2 diabetic nephropathy patients, 39 stage 3 diabetic nephropathy patients, and 12 nondiabetic subjects performed five submaximal cycloergometric exercises (90% of theoretical heart rate) on nonconsecutive days." | 6.67 | Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. ( Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G, 1990) |
| " Dosage of nifedipine or efonidipine was chosen after preliminary studies demonstrated that it showed moderate antihypertensive action (more than a 20% decrease in systemic blood pressure after treatment)." | 5.30 | Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes. ( Kaneko, S; Shou, I; Takeda, M; Takizawa, H; Tomino, Y, 1999) |
| "It is revealed that only nifedipine CR and cilnidipine could reduce albuminuria statistically." | 5.17 | A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers. ( Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Morikawa, N; Nakamura, H; Wakahara, S, 2013) |
| " In the present analysis, we used data from the TALENT study to evaluate soluble receptor for advanced glycation end-products (sRAGE) plasma levels in patients with hypertension and high-cardiovascular risk-treated nifedipine and telmisartan in combination." | 5.16 | Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT. ( Boiocchi, C; Bozzini, S; Buzzi, MP; Choi, J; D'Angelo, A; Esposito, C; Falcone, C; Mancia, G; Ochan Kilama, M; Schirinzi, S; Torreggiani, M, 2012) |
| "Long-term control of blood pressure with perindopril or nifedipine stabilizes AER and attenuates GFR decline in proportion to MAP in non-hypertensive patients with Type 2 diabetes and microalbuminuria." | 5.11 | Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. ( Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; O'Brien, RC; Raffaele, J; Tsalamandris, C, 2004) |
| "These findings suggest that the low-dose combination therapy of nifedipine CR and candesartan is superior to the up-titrated monotherapy of candesartan in terms of blood pressure control and renal protection in patients with essential hypertension." | 5.11 | Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study. ( Hasebe, N; Kikuchi, K, 2005) |
| " A total of 54 type 1 diabetic patients with albuminuria and blood pressure (BP) <150/90 mmHg were randomized to receive 10 mg enalapril once daily, 10 mg nifedipine retard twice daily, or placebo in a multicenter double-blind study of 3 years' duration." | 5.09 | Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT). ( , 2001) |
| "To examine the effect of perindopril and nifedipine on renal function in patients with essential hypertension (EH)." | 5.09 | [Greater reduction of urinary albumin excretion in hypertensive patients with perindopril than nifedipine]. ( Chen, D; Lin, J; Wu, K, 1999) |
| "The purpose of the study was to compare the effect of treatment with an angiotensin converting enzyme inhibitor (Lisinopril, MSD) or calcium blocker (Nifedipine retard, MSD) treatment during three months on blood pressure (measured with sphygmomanometric method and ambulatory blood pressure monitoring--ABPM) and urinary albumin excretion in essential hypertension class I acc." | 5.08 | [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension]. ( Celibała, R; Czekalski, S; Widecka, K, 1995) |
| "To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 5.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
| "Our data show that both lisinopril and nifedipine are effective in delaying the occurrence of macroalbuminuria in normotensive IDDM patients with MA." | 5.08 | Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. ( Carta, Q; Crepaldi, G; Deferrari, G; Mangili, R; Navalesi, R; Nosadini, R; Santeusanio, F; Spalluto, A; Vanasia, A; Villa, GM, 1998) |
| " In a prospective randomized study, 14 patients with NIDDM, hypertension, proteinuria, and renal insufficiency were given either isradipine (n = 7) or nifedipine XL (n = 7) for 6 months." | 5.08 | Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes. ( Abbott, K; Bakris, GL; Smith, A, 1996) |
| "In the patients treated with enalapril, albuminuria decreased from 143 +/- 64 (mean +/- SD) mg/24 h to 122 +/- 67 mg/24 h during the first year." | 5.07 | Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. ( Bental, T; Jutrin, I; Katz, B; Lishner, M; Ravid, M; Savin, H, 1993) |
| "Randomised study of diabetic patients with microalbuminuria treated with perindopril or nifedipine for 12 months and monitored for one or three months after stopping treatment depending on whether they were hypertensive or normotensive." | 5.07 | Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. ( , 1991) |
| "The aim of the present study was to investigate the renal effects of long-term treatment with the calcium channel blocker nifedipine in normotensive type 1 diabetic patients with microalbuminuria." | 5.07 | Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. ( Banyai, M; Capek, M; Kautzky-Willer, A; Prager, R; Schernthaner, G; Schnack, C, 1994) |
| "The effects of nifedipine retard and captopril on renal haemodynamic parameters have been examined in a double blind randomised cross-over trial in 10 insulin-dependent diabetic males with hypertension (systolic pressure > 150 mmHg or diastolic pressure > 90 mmHg)." | 5.07 | Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study. ( Clarke, BF; Cowan, P; Jenkins, DA; Patrick, AW, 1993) |
| "The acute effects of buccal nifedipine 20 mg on blood pressure, renal haemodynamics and electrolyte excretion were compared in 16 untreated patients (HT) with uncomplicated arterial hypertension (WHO I-II), 11 normotensives (NT) and 6 normotensives given a placebo." | 5.06 | Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls--a proximal tubular effect? ( Christensen, CK; Krusell, LR; Lederballe Pedersen, O, 1987) |
| " Reduction of microalbuminuria at 27 weeks, compared to the vehicle group, was 37% and 52% in the enalapril- and nilvadipine-treated groups, respectively." | 3.72 | Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes. ( Imai, E; Moriyama, T; Oka, K; Ueda, H, 2004) |
| "The short-term effects of nifedipine on glomerular hemodynamics, sieving function, and renal tubular function were assessed in 10 patients suffering from biopsy-verified chronic glomerulonephritis." | 3.69 | Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients. ( Berg, KJ; Fauchald, P; Hartmann, A; Holdaas, H; Lund, K; Reisaeter, A, 1994) |
| "The effects on blood pressure and renal function of a single 20-mg sublingual dose of nifedipine were investigated in 10 patients with mild to moderate arterial hypertension insufficiently treated on beta-blocker monotherapy." | 3.66 | Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs. ( Christensen, CK; Lederballe Pedersen, O; Mikkelsen, E, 1982) |
| " In the first 3 months, drug dosage was titrated to achieve a decrease in diastolic blood pressure of at least 5 mm HG: Thirty-three patients had a minimum of 24 months' data, and 25 patients were followed up beyond 36 months (mean, 67 +/- 4 months)." | 2.70 | Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria. ( Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; Raffaele, J; Tsalamandris, C, 2001) |
| "Treatment with enalapril was associated with a greater reduction in albuminuria than with nifedipine in the entire patient group, and especially in those with microalbuminuria." | 2.69 | Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. ( Chan, JC; Cheung, MY; Cheung, RC; Cockram, CS; Critchley, JA; Ko, GT; Leung, DH; Nicholls, MG; So, WY; Swaminathan, R, 2000) |
| "Treatment with enalapril for 48 months may have a beneficial effect on the decline of microalbumin excretion in NIDDM patients." | 2.67 | Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. ( Hara, T; Hotta, N; Kawamura, T; Matsumae, H; Matsuo, S; Nakayama, M; Sakamoto, N; Sano, T; Sasaki, H, 1994) |
| " We therefore conclude, that long-term use of nifedipine increases UAER in normotensive microalbuminuric insulin-dependent subjects, in contrast to captopril or placebo." | 2.67 | Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus. ( Bakker, K; Bilo, H; Donker, A; Gans, R; Kluitman, E; Michels, B; Potter van Loon, BJ; van Ballegooie, E, 1993) |
| "Twelve patients with type 1 diabetes with albuminuria, mild to moderate hypertension and a serum creatinine level of less than 200 mumol l-1 were included." | 2.67 | Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. ( Berg, KJ; Djøseland, O; Endresen, L; Fauchald, P; Hartmann, A; Holdaas, H; Jervell, J; Lien, MG; Nilsen, L, 1991) |
| "Twenty-five stage 2 diabetic nephropathy patients, 39 stage 3 diabetic nephropathy patients, and 12 nondiabetic subjects performed five submaximal cycloergometric exercises (90% of theoretical heart rate) on nonconsecutive days." | 2.67 | Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. ( Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G, 1990) |
| "We examined renal responses to a pharmacological dosage of human atrial natriuretic peptide (hANP) and the potential interference of nifedipine administration with the effects of hANP on kidney function in healthy subjects and normoglycemic patients with type 1 diabetes mellitus." | 2.66 | Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus. ( Hofmann, E; Jungmann, E; Scheuermann, EH; Schöffling, K; Seel, K, 1989) |
| " Dosage of nifedipine or efonidipine was chosen after preliminary studies demonstrated that it showed moderate antihypertensive action (more than a 20% decrease in systemic blood pressure after treatment)." | 1.30 | Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes. ( Kaneko, S; Shou, I; Takeda, M; Takizawa, H; Tomino, Y, 1999) |
| "Verapamil was more effective than nifedipine in improving natriuresis and ANP release to saline load and in lowering the albumin excretion rate." | 1.28 | Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. ( Abaterusso, C; Brocco, E; Carraro, A; Cipollina, MR; Fioretto, P; Frigato, F; Muollo, B; Riva, F; Trevisan, M; Velussi, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (12.77) | 18.7374 |
| 1990's | 26 (55.32) | 18.2507 |
| 2000's | 11 (23.40) | 29.6817 |
| 2010's | 4 (8.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z | 1 |
| Wang, XY | 1 |
| Yan, NN | 1 |
| Ishii, T | 1 |
| Kawamura, T | 2 |
| Tsuboi, N | 1 |
| Hosoya, T | 1 |
| Nakagawa, N | 1 |
| Fujino, T | 1 |
| Kabara, M | 1 |
| Matsuki, M | 1 |
| Chinda, J | 1 |
| Kikuchi, K | 2 |
| Hasebe, N | 2 |
| Konoshita, T | 1 |
| Makino, Y | 1 |
| Kimura, T | 1 |
| Fujii, M | 1 |
| Morikawa, N | 1 |
| Wakahara, S | 1 |
| Arakawa, K | 1 |
| Inoki, I | 1 |
| Nakamura, H | 1 |
| Miyamori, I | 1 |
| Falcone, C | 1 |
| Buzzi, MP | 1 |
| Bozzini, S | 1 |
| Boiocchi, C | 1 |
| D'Angelo, A | 1 |
| Schirinzi, S | 1 |
| Esposito, C | 1 |
| Torreggiani, M | 1 |
| Choi, J | 1 |
| Ochan Kilama, M | 1 |
| Mancia, G | 1 |
| White, KE | 1 |
| Bilous, RW | 1 |
| Marshall, SM | 1 |
| El Nahas, M | 1 |
| Remuzzi, G | 1 |
| Piras, G | 1 |
| De Cosmo, S | 1 |
| Viberti, G | 1 |
| Moriyama, T | 1 |
| Oka, K | 1 |
| Ueda, H | 1 |
| Imai, E | 1 |
| Jerums, G | 2 |
| Allen, TJ | 2 |
| Campbell, DJ | 2 |
| Cooper, ME | 2 |
| Gilbert, RE | 2 |
| Hammond, JJ | 2 |
| O'Brien, RC | 1 |
| Raffaele, J | 2 |
| Tsalamandris, C | 2 |
| Christensen, CK | 2 |
| Lederballe Pedersen, O | 2 |
| Mikkelsen, E | 1 |
| García Puig, J | 1 |
| Mateos Antón, F | 1 |
| Gil Aguado, A | 1 |
| Barcina Sánchez, C | 1 |
| Widecka, K | 1 |
| Celibała, R | 1 |
| Czekalski, S | 1 |
| Hartmann, A | 2 |
| Lund, K | 1 |
| Holdaas, H | 2 |
| Fauchald, P | 2 |
| Reisaeter, A | 1 |
| Berg, KJ | 2 |
| Chan, JC | 3 |
| Nicholls, MG | 3 |
| Cheung, CK | 2 |
| Law, LK | 1 |
| Swaminathan, R | 3 |
| Cockram, CS | 3 |
| Parving, HH | 1 |
| Rossing, P | 1 |
| Hommel, E | 1 |
| Smidt, UM | 1 |
| Bilo, H | 1 |
| Kluitman, E | 1 |
| van Ballegooie, E | 1 |
| Potter van Loon, BJ | 1 |
| Bakker, K | 1 |
| Michels, B | 1 |
| Gans, R | 1 |
| Donker, A | 1 |
| Schnack, C | 1 |
| Capek, M | 1 |
| Banyai, M | 1 |
| Kautzky-Willer, A | 1 |
| Prager, R | 1 |
| Schernthaner, G | 1 |
| Sano, T | 1 |
| Matsumae, H | 1 |
| Sasaki, H | 1 |
| Nakayama, M | 1 |
| Hara, T | 1 |
| Matsuo, S | 1 |
| Hotta, N | 1 |
| Sakamoto, N | 1 |
| Jenkins, DA | 1 |
| Cowan, P | 1 |
| Patrick, AW | 1 |
| Clarke, BF | 1 |
| Ravid, M | 1 |
| Savin, H | 1 |
| Jutrin, I | 1 |
| Bental, T | 1 |
| Katz, B | 1 |
| Lishner, M | 1 |
| Crepaldi, G | 2 |
| Carraro, A | 2 |
| Brocco, E | 2 |
| Adezati, L | 1 |
| Andreani, D | 1 |
| Bompiani, G | 1 |
| Brunetti, P | 1 |
| Fedele, D | 1 |
| Giorgino, R | 1 |
| Giustina, G | 4 |
| Bakris, GL | 2 |
| Smith, A | 2 |
| Abbott, K | 1 |
| Agardh, CD | 1 |
| Garcia-Puig, J | 1 |
| Charbonnel, B | 1 |
| Angelkort, B | 1 |
| Barnett, AH | 1 |
| Carta, Q | 1 |
| Deferrari, G | 2 |
| Mangili, R | 1 |
| Navalesi, R | 1 |
| Santeusanio, F | 1 |
| Spalluto, A | 1 |
| Vanasia, A | 1 |
| Villa, GM | 1 |
| Nosadini, R | 1 |
| Monteiro de Freitas, AS | 1 |
| Coimbra, TM | 1 |
| Costa, RS | 1 |
| Baroni, EA | 1 |
| Kaneko, S | 1 |
| Takizawa, H | 1 |
| Takeda, M | 1 |
| Shou, I | 1 |
| Tomino, Y | 1 |
| Ko, GT | 1 |
| Leung, DH | 1 |
| Cheung, RC | 1 |
| Cheung, MY | 1 |
| So, WY | 1 |
| Critchley, JA | 1 |
| Baba, S | 1 |
| Lin, J | 1 |
| Chen, D | 1 |
| Wu, K | 1 |
| Leoncini, G | 1 |
| Martinoli, C | 1 |
| Viazzi, F | 1 |
| Ravera, M | 1 |
| Parodi, D | 1 |
| Ratto, E | 1 |
| Vettoretti, S | 1 |
| Tomolillo, C | 1 |
| Derchi, LE | 1 |
| Pontremoli, R | 1 |
| Redon, J | 1 |
| Rovira, E | 1 |
| Miralles, A | 1 |
| Julve, R | 1 |
| Pascual, JM | 1 |
| Fioretto, P | 1 |
| Frigato, F | 1 |
| Velussi, M | 1 |
| Riva, F | 1 |
| Muollo, B | 1 |
| Cipollina, MR | 1 |
| Abaterusso, C | 1 |
| Trevisan, M | 1 |
| Dawnay, A | 1 |
| Wilson, AG | 1 |
| Lamb, E | 1 |
| Kirby, JD | 1 |
| Cattell, WR | 1 |
| Lien, MG | 1 |
| Nilsen, L | 1 |
| Jervell, J | 1 |
| Endresen, L | 1 |
| Djøseland, O | 1 |
| Romanelli, G | 3 |
| Giustina, A | 3 |
| Cravarezza, P | 2 |
| Caldonazzo, A | 2 |
| Agabiti-Rosei, E | 2 |
| Bossoni, S | 2 |
| Cimino, A | 1 |
| Jungmann, E | 1 |
| Seel, K | 1 |
| Hofmann, E | 1 |
| Scheuermann, EH | 1 |
| Schöffling, K | 1 |
| Girelli, A | 1 |
| Muiesan, ML | 1 |
| Muiesan, G | 1 |
| Mickisch, O | 1 |
| Schmid, M | 1 |
| Mann, JF | 1 |
| Helder, T | 1 |
| Bergen, F | 1 |
| Rauterberg, EW | 1 |
| Ritz, E | 1 |
| Insua, A | 1 |
| Ribstein, J | 1 |
| Mimran, A | 1 |
| Krusell, LR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Renal Doppler Ultrasound in Early Detection of Acute Kidney Injury in Critically Ill Patients[NCT03902483] | 80 participants (Anticipated) | Observational | 2019-07-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 trials available for nifedipine and Albuminuria
| Article | Year |
|---|---|
[Treatment of albuminuria in gestational hypertension puerpera in the severe preeclampeia stage by TCM therapy for stasis-removing and diuresis].
Topics: Adult; Albuminuria; Diagnosis, Differential; Drug Therapy, Combination; Drugs, Chinese Herbal; Femal | 2009 |
Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles | 2011 |
A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.
Topics: Aged; Aged, 80 and over; Albuminuria; Biomarkers; Calcium Channel Blockers; Cardiovascular Diseases; | 2013 |
Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.
Topics: Adolescent; Adult; Aged; Albuminuria; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combi | 2012 |
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Blood Pressure; Calcium Channe | 2002 |
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mel | 2004 |
Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Antihypertensive Agents; Benzimidazoles; Bi | 2005 |
[Can the "double blind" be recognized before the identifying codes are revealed?].
Topics: Albuminuria; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hy | 1995 |
[Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blocke | 1995 |
Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Topics: Albuminuria; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Blood P | 1995 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; C | 1995 |
Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus.
Topics: Adult; Albuminuria; Captopril; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Male; | 1993 |
Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.
Topics: Adult; Albuminuria; Blood Chemical Analysis; Blood Pressure; Diabetes Mellitus, Type 1; Double-Blind | 1994 |
Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients.
Topics: Acetylglucosaminidase; Albuminuria; beta 2-Microglobulin; Blood Pressure; Body Weight; Cholesterol; | 1994 |
Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
Topics: Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Double-Blind Method; Human | 1993 |
Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
Topics: Adult; Albuminuria; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; D | 1993 |
Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood | 1995 |
Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
Topics: Aged; Albuminuria; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Cross-Over Studies; | 1996 |
Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes.
Topics: Adult; Albuminuria; Calcium Channel Blockers; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, S | 1996 |
Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Topics: Adolescent; Adult; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blin | 1996 |
Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Diab | 1998 |
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Diabetes Mellitus, Type 2; | 2000 |
Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium | 2001 |
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Age | 2001 |
Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Disea | 2001 |
[Greater reduction of urinary albumin excretion in hypertensive patients with perindopril than nifedipine].
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rat | 1999 |
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blocke | 2002 |
Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihyper | 2002 |
Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.
Topics: Albuminuria; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; | 1992 |
Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Blood Pressure; | 1991 |
Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetes Melli | 1991 |
Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diab | 1991 |
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Topics: Administration, Oral; Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Capt | 1990 |
Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus.
Topics: Administration, Buccal; Adult; Albuminuria; Atrial Natriuretic Factor; Blood Pressure; Diabetes Mell | 1989 |
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients.
Topics: Albuminuria; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Evaluation; Exerc | 1989 |
[Calcium antagonists in chronic renal failure. Undesirable effects on glomerular hemodynamics?].
Topics: Adult; Albuminuria; Calcium Channel Blockers; Enalapril; Hemodynamics; Humans; Hypertension, Renal; | 1988 |
Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 1; | 1988 |
Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls--a proximal tubular effect?
Topics: Adult; Albuminuria; beta 2-Microglobulin; Blood Pressure; Body Water; Humans; Hypertension; Kidney T | 1987 |
9 other studies available for nifedipine and Albuminuria
| Article | Year |
|---|---|
[CCB uptitration is superior to ARB uptitration in CKD patients who do not reach target blood pressure with ARB/CCB combined therapy].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Chro | 2010 |
Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body | 2004 |
Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs.
Topics: Adult; Albuminuria; beta 2-Microglobulin; Blood Pressure; Female; Heart Rate; Humans; Hypertension; | 1982 |
Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients.
Topics: Adult; Aged; Albuminuria; Blood Pressure; Chronic Disease; Dextrans; Female; Glomerular Filtration R | 1994 |
Which one of the following antihypertensive medications is the least appropriate choice for patients with diabetic nephropathy. Nifedipine (e.g., Adalat) is the least appropriate choice for patients with diabetic nephropathy.
Topics: Albuminuria; Antihypertensive Agents; Calcium Channel Blockers; Diabetic Nephropathies; Humans; Nife | 1997 |
Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: effect of enalapril and nifedipine.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Bloc | 1998 |
Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
Topics: Albuminuria; Animals; Antihypertensive Agents; Creatinine; Diabetes Mellitus, Experimental; Diabetic | 1999 |
Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Calcium Cha | 1992 |
Microalbuminuria in systemic sclerosis.
Topics: Adult; Aged; Albuminuria; Creatinine; Female; Humans; Male; Middle Aged; Nifedipine; Prospective Stu | 1992 |